Hepatitis Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis C Virus Therapy
New hepatitis C virus therapy research from University Hospital discussed
August 6th, 2007
Data detailed in "CCL2-2518 A/G and CCR2 190 A/G do not influence the outcome of hepatitis C virus infection in the Spanish population" have been presented. In this recent report, researchers in Seville, Spain conducted a study "To assess whether CCL2 or interactions between this chemokine and its receptor (CCR2) are associated with outcomes of chronic hepatitis C and with responses to antiviral therapy. Two hundred and eighty-four patients with chronic hepatitis C and 193 non-infected matched controls were included in this study." "Patients were categorized according to their Scheuer score of hepatic fibrosis as F0-F2 (n=202) or F3-F4 (n=82) and according to their...
Source: Hepatitis Weekly (2007-08-06)
|
